MRNA · Large Cap · NASDAQ · Healthcare · Biotechnology
Free AI brief
Free to track. No card required. Usually ready in 10-15 minutes.
Price, momentum, and the numbers behind the story.
Stocksbrew score
47/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
Free for 3 days, then $9/mo. Cancel anytime.
Where the analysts and the crowd stand, and what it's worth to know first.
Lowest
$45
Median target
$125
Current price
$154.01
Highest
$170
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
Debt / equity
Favorable · 0.18 - strong leverage
0.19x
Current ratio
Strong · Good liquidity position
2.29x
Price / sales
Rich · Overpriced by revenue
27.60x
ROIC
Weak · Weak capital efficiency
-76.0%
ROE
Needs attention · Unfavorable
-39.0%
MRNA against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $61.50B | - | -27.6% | 47 | |
| $9.95B | 18.9 | +19.7% | 78 | |
| $33.72B | 35.3 | +15.5% | 78 | |
| $4.12B | 12.4 | +13.5% | 78 | |
| $1.09T | 39.2 | +49.6% | 77 |
Every story that touched the stock this week, newest first.